250
[Results] 17 weeks, 36kg, and denial was the hard part
Long-ish post, sorry. tl;dr at the bottom. I have been tracking appeal against ApoB for 17 weeks because I could not find anyone who had. The correlation is weaker than…
u/sofia_nascimento
Contributes reviews on supplier material. Based in Verona.
member · joined 17 Aug 2025
17,723post karma
8,482comment karma
5submissions
79comments
Overview — page 3 of 5
comment on small win: VendorInvestigate stopped being a problem at week 55 in c/vendorvetting · 17 points · 11 months ago
Did you test the vial you received or are we going off the vendor COA?
comment on anyone else notice SURMOUNT kicking in around week 20 in c/tirzepatide · 100 points · 11 months ago
week 28 on Mounjaro and the appetite profile is genuinely different from sema
comment on anyone else notice SURMOUNT kicking in around week 20 in c/tirzepatide · 51 points · 11 months ago
week 13 on Mounjaro and the appetite profile is genuinely different from sema
comment on telehealth is the most under-discussed thing in c/progresspics in c/compounding · 27 points · 11 months ago
regulatory claims need a citation to the actual rule, not interpretation
comment on GIP: what the trials say vs what this community says in c/tirzepatide · 0 points · 12 months ago
SURMOUNT data is messier than STEP data but the weight loss is there
comment on unpopular opinion: 15mg is massively overrated in c/tirzepatide · 104 points · 1 year ago
How long at each step before you escalated?
comment on unpopular opinion: 15mg is massively overrated in c/tirzepatide · 117 points · 1 year ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
Yes, exactly this, and it is the bit that took me 24 weeks to accept.
comment on API source: the version I wish someone had shown me in week 1 in c/compounding · 23 points · 1 year ago
Yeah, 503A and 503B are different regulatory animals.
comment on [Discussion] telehealth is doing more work than we give it credit for in c/compounding · 1 points · 1 year ago
Strongly agree. API source transparency matters.
comment on [Results] 17 weeks, 36kg, and denial was the hard part in c/insurancefights · 1 points · 1 year ago
external review is the appeal after insurance says no
comment on [Results] 17 weeks, 36kg, and denial was the hard part in c/insurancefights · 0 points · 1 year ago
Which plan type? prior authorization is different.
comment on what would you tell week-1 you about compounding in c/compounding · 28 points · 1 year ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on am I the only one who found formulary harder than the injections in c/insurancefights · 8 points · 1 year ago
say which country and which plan type
comment on [Question] how do you actually verify Medutest in c/vendorvetting · 27 points · 1 year ago
order date, product, and what was tested. that is the template.
comment on why does nobody talk about Mounjaro in c/tirzepatide · 56 points · 1 year ago
Did you stay on semaglutide or switch? The outcome is different if you are comparing.
comment on 6 months in and shortage list is still the thing I get wrong in c/compounding · 165 points · 1 year ago
telehealth costs state board plus compounding markup, total varies
comment on Janoshik vs order records — genuinely asking which matters more in c/vendorvetting · 95 points · 1 year ago
Respectfully this is a sample of one presented as a finding.
comment on [Results] 6 weeks on 12.5mg, full numbers, ask me anything boring in c/vendorvetting · 178 points · 1 year ago
The confident tone is doing a lot of work that the evidence is not.
comment on nobody warned me about injection-site soreness and I would have liked the warning in c/tirzepatide · 244 points · 1 year ago
week 72 on Mounjaro and the appetite profile is genuinely different from sema